Tag Archives: sharply

Stock Market Today: Tech-heavy Nasdaq drops sharply; Dow and S&P 500 fall after PCE inflation report as stocks head for weekly decline – MarketWatch

Stock Market Today: Tech-heavy Nasdaq drops sharply; Dow and S&P 500 fall after PCE inflation report as stocks head for weekly decline  MarketWatch Stock market today: Dow, S&P 500, Nasdaq fall from records after PCE inflation data  Yahoo Finance Wall St falls as Dell, Nvidia drive tech losses  Reuters Stock Market Today: Dow Falls 100 Points; Inflation Holds Above Target — Live Updates  The …

Read More »

S&P 500, Dow Retreat From Record Highs as Tech Stocks Tumble; Nvidia, Broadcom Down Sharply

S&P 500, Dow Retreat From Record Highs as Tech Stocks Tumble; Nvidia, Broadcom Down Sharply

Autodesk Stock Surges Amid Growing AI-Related Demand 56 minutes ago Autodesk (ADSK) shares surged Friday after the company posted better-than-expected results and raised its guidance on demand for its design software for artificial intelligence data centers. Autodesk late Thursday reported fiscal 2026 second-quarter adjusted earnings per share (EPS) of $2.62, with revenue rising 17% year-over-year to $1.76 billion. Both exceeded forecasts. Billings …

Read More »

U.S. trade deficit in goods widened sharply in July as firms raced to avoid tariffs – MarketWatch

U.S. trade deficit in goods widened sharply in July as firms raced to avoid tariffs  MarketWatch US goods trade deficit widens sharply in July  Reuters U.S. releases advance July goods trade, inventories data  TradingView The U.S. Goods Trade Deficit: A Looming Drag on Q3 Growth and Investment Implications  AInvest S&P 500 Sinks on Alarming Trade Deficit Report  TipRanks Source link

Read More »

Crypto Traders Eye Jackson Hole as Ether, XRP, Solana Drop Sharply

Crypto Traders Eye Jackson Hole as Ether, XRP, Solana Drop Sharply

Shaurya is the Co-Leader of the CoinDesk tokens and data team in Asia with a focus on crypto derivatives, DeFi, market microstructure, and protocol analysis. Shaurya holds over $1,000 in BTC, ETH, SOL, AVAX, SUSHI, CRV, NEAR, YFI, YFII, SHIB, DOGE, USDT, USDC, BNB, MANA, MLN, LINK, XMR, ALGO, VET, CAKE, AAVE, COMP, ROOK, TRX, SNX, RUNE, FTM, ZIL, KSM, …

Read More »

China’s Economy Slows Sharply as Trade War Bites – Bloomberg.com

China’s Economy Slows Sharply as Trade War Bites  Bloomberg.com China’s growth stumbles in July as retail sales, industrial output miss forecasts  CNBC China’s Economy Slows Broadly Even as Exports Keep Rising  The New York Times China’s economy lags in July under pressure from tariffs and a weak property market  Yahoo Finance China’s factory output, retail sales growth slump in blow to economy  Reuters Source link

Read More »

White House sharply lowers expectations for Trump-Putin summit – The Washington Post

White House sharply lowers expectations for Trump-Putin summit  The Washington Post White House lands on Trump-Putin summit location as officials race to prepare for historic Alaska meeting  CNN Will Trump fall into Putin’s trap?  The Hill Zelenskyy not invited to upcoming Trump, Putin talks — White House says this was the reason  Fox News Leavitt, 27, Scrambles to Justify 79-Year-Old Trump’s Senior Moment  yahoo.com Source …

Read More »

Tariffs on China Set to Rise Sharply Tuesday if No Deal Is Reached – The New York Times

Tariffs on China Set to Rise Sharply Tuesday if No Deal Is Reached  The New York Times U.S.-China high-stakes tariff truce extension hangs in the balance as deadline looms  CNBC US-China tariff truce deadline arrives  Financial Times A pause on higher tariffs for China is due to expire Tuesday. Here’s what to know  AP News Expectations grow for US-China trade truce  Politico Source link

Read More »

Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply | Pharmaceuticals industry

Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply | Pharmaceuticals industry

Sales of Novo Nordisk’s injectable diabetes drugs including Ozempic have slowed sharply amid fierce competition and the threat of US tariffs, prompting it to cut costs and sharpen its commercial focus. The Danish drugmaker, whose booming sales of GLP-1 diabetes and obesity drugs in recent years had turned it into Europe’s most valuable company, has lost nearly $100bn (£75bn) in …

Read More »